6550--Benchmark Ultra Plus
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office 17, has awarded a Firm Fixed-Price contract valued at $132,000.00 to ROCHE DIAGNOSTICS CORPORATION for a VENTANA BenchMark ULTRA PLUS Immunohistochemistry / In Situ Hybridization (IHC/ISH) stainer system. This award follows a sole source intent.
Scope of Work
The contract covers the provision of one VENTANA BenchMark ULTRA PLUS IHC/ISH stainer system, including required system software, an uninterruptible power supply (UPS), monitor, scanner, and printer. The system must be fully automated, random-access, capable of continuous loading, and feature error-proof reagent design. It is also required to be compatible with the existing VENTANA assay portfolio and current Roche agreement. The award includes technical support, customer training, installation, instrument validation guidance, and preventive maintenance. The system will be installed in the Histology Section, Room 1B-328, at the VA North Texas Health Care System in Dallas, TX.
Contract & Timeline
- Type: Firm Fixed-Price
- Award Number: 36C25726P0473
- Award Amount: $132,000.00
- Awardee: ROCHE DIAGNOSTICS CORPORATION (UEI: JDMDFEZBYH36)
- Award Date: May 14, 2026
- Published Date: May 15, 2026
- Set-Aside: None (awarded via sole source justification)
- Period of Performance: Begins upon award through completion of installation, validation, training, and warranty/service obligations.
Evaluation
This award was made on a sole source basis to Roche Diagnostics Corporation under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.302-1, citing only one responsible source. The rationale was based on the unique compatibility of the VENTANA BenchMark ULTRA PLUS system with the VA North Texas Histology section's existing infrastructure, reagents, and workflows, where substituting a different platform would require extensive revalidation, increased costs, and risk disruption to patient care.
Additional Notes
This award notice (36C25726P0473) is the result of a previous Notice of Intent to Sole Source (36C25726Q0447). The contractor will have supervised access to VA premises for installation and service only, with no access to the VA laboratory information system (LIS) or VA data transfer.